These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 35266849)
1. Molecular Targets of Curcumin and Its Therapeutic Potential for Ovarian Cancer. Mohamadian M; Bahrami A; Moradi Binabaj M; Asgharzadeh F; Ferns GA Nutr Cancer; 2022; 74(8):2713-2730. PubMed ID: 35266849 [TBL] [Abstract][Full Text] [Related]
2. Potential application of curcumin and its analogues in the treatment strategy of patients with primary epithelial ovarian cancer. Terlikowska KM; Witkowska AM; Zujko ME; Dobrzycka B; Terlikowski SJ Int J Mol Sci; 2014 Nov; 15(12):21703-22. PubMed ID: 25429431 [TBL] [Abstract][Full Text] [Related]
3. Molecular targets of curcumin in breast cancer (Review). Song X; Zhang M; Dai E; Luo Y Mol Med Rep; 2019 Jan; 19(1):23-29. PubMed ID: 30483727 [TBL] [Abstract][Full Text] [Related]
4. The versatile role of curcumin in cancer prevention and treatment: A focus on PI3K/AKT pathway. Hamzehzadeh L; Atkin SL; Majeed M; Butler AE; Sahebkar A J Cell Physiol; 2018 Oct; 233(10):6530-6537. PubMed ID: 29693253 [TBL] [Abstract][Full Text] [Related]
6. The inhibitory effect of curcumin via fascin suppression through JAK/STAT3 pathway on metastasis and recurrence of ovary cancer cells. Kim MJ; Park KS; Kim KT; Gil EY BMC Womens Health; 2020 Nov; 20(1):256. PubMed ID: 33213437 [TBL] [Abstract][Full Text] [Related]
7. Targeting Signaling Pathway by Curcumin in Osteosarcoma. Farnood PR; Pazhooh RD; Asemi Z; Yousefi B Curr Mol Pharmacol; 2023; 16(1):71-82. PubMed ID: 35400349 [TBL] [Abstract][Full Text] [Related]
8. Gemini Curcumin Suppresses Proliferation of Ovarian Cancer OVCAR-3 Cells via Induction of Apoptosis. Ghaderi S; Babaei E; Hussen BM; Mahdavi M; Azeez HJ Anticancer Agents Med Chem; 2021; 21(6):775-781. PubMed ID: 32767955 [TBL] [Abstract][Full Text] [Related]
9. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling. Watson JL; Greenshields A; Hill R; Hilchie A; Lee PW; Giacomantonio CA; Hoskin DW Mol Carcinog; 2010 Jan; 49(1):13-24. PubMed ID: 19676105 [TBL] [Abstract][Full Text] [Related]
10. Re-purposing of curcumin as an anti-metastatic agent for the treatment of epithelial ovarian cancer: in vitro model using cancer stem cell enriched ovarian cancer spheroids. He M; Wang D; Zou D; Wang C; Lopes-Bastos B; Jiang WG; Chester J; Zhou Q; Cai J Oncotarget; 2016 Dec; 7(52):86374-86387. PubMed ID: 27863439 [TBL] [Abstract][Full Text] [Related]
11. Curcuma as an adjuvant in colorectal cancer treatment. Villegas C; Perez R; Sterner O; González-Chavarría I; Paz C Life Sci; 2021 Dec; 286():120043. PubMed ID: 34637800 [TBL] [Abstract][Full Text] [Related]
12. Potential Mechanisms of Action of Curcumin for Cancer Prevention: Focus on Cellular Signaling Pathways and miRNAs. Wang M; Jiang S; Zhou L; Yu F; Ding H; Li P; Zhou M; Wang K Int J Biol Sci; 2019; 15(6):1200-1214. PubMed ID: 31223280 [TBL] [Abstract][Full Text] [Related]
13. Curcumin induces apoptotic cell death and protective autophagy by inhibiting AKT/mTOR/p70S6K pathway in human ovarian cancer cells. Liu LD; Pang YX; Zhao XR; Li R; Jin CJ; Xue J; Dong RY; Liu PS Arch Gynecol Obstet; 2019 Jun; 299(6):1627-1639. PubMed ID: 31006841 [TBL] [Abstract][Full Text] [Related]
14. Curcumin prevented human autocrine growth hormone (GH) signaling mediated NF-κB activation and miR-183-96-182 cluster stimulated epithelial mesenchymal transition in T47D breast cancer cells. Coker-Gurkan A; Bulut D; Genc R; Arisan ED; Obakan-Yerlikaya P; Palavan-Unsal N Mol Biol Rep; 2019 Feb; 46(1):355-369. PubMed ID: 30467667 [TBL] [Abstract][Full Text] [Related]
15. Curcumin Regulates Cancer Progression: Focus on ncRNAs and Molecular Signaling Pathways. Wang H; Zhang K; Liu J; Yang J; Tian Y; Yang C; Li Y; Shao M; Su W; Song N Front Oncol; 2021; 11():660712. PubMed ID: 33912467 [TBL] [Abstract][Full Text] [Related]
16. Curcumin downregulates the PI3K-AKT-mTOR pathway and inhibits growth and progression in head and neck cancer cells. Borges GA; Elias ST; Amorim B; de Lima CL; Coletta RD; Castilho RM; Squarize CH; Guerra ENS Phytother Res; 2020 Dec; 34(12):3311-3324. PubMed ID: 32628350 [TBL] [Abstract][Full Text] [Related]
17. The targets of curcumin. Zhou H; Beevers CS; Huang S Curr Drug Targets; 2011 Mar; 12(3):332-47. PubMed ID: 20955148 [TBL] [Abstract][Full Text] [Related]
18. Modulation of microRNAs expression and cellular signaling pathways through curcumin as a potential therapeutical approach against ovarian cancer: A review. Moazzami B; Chaichian S; Nikfar B; Arbabi Bidgoli S Pathol Res Pract; 2023 Jul; 247():154527. PubMed ID: 37235907 [TBL] [Abstract][Full Text] [Related]
19. Sensing the scent of death: Modulation of microRNAs by Curcumin in gastrointestinal cancers. Ashrafizadeh M; Zarrabi A; Hashemipour M; Vosough M; Najafi M; Shahinozzaman M; Hushmandi K; Khan H; Mirzaei H Pharmacol Res; 2020 Oct; 160():105199. PubMed ID: 32942019 [TBL] [Abstract][Full Text] [Related]
20. Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer cells and modulate Wnt/β-catenin signaling and apoptotic pathways in A375 cells. Srivastava NS; Srivastava RAK Phytomedicine; 2019 Jan; 52():117-128. PubMed ID: 30599890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]